


Searching News Database: NAFLD
HSMN NewsFeed - 25 Jun 2025
Viking Therapeutics Announces Initiation of Phase 3 Obesity Clinical Program with GLP-1/GIP Agonist VK2735
Viking Therapeutics Announces Initiation of Phase 3 Obesity Clinical Program with GLP-1/GIP Agonist VK2735
HSMN NewsFeed - 25 Oct 2018
89Bio Launches into Liver and Metabolic Disorders with $60 Million Series A Financing
89Bio Launches into Liver and Metabolic Disorders with $60 Million Series A Financing
HSMN NewsFeed - 30 Nov 2017
Fractyl Appoints Senator William W. Bradley and Dr. John Amatruda to the Company's Board of Directors
Fractyl Appoints Senator William W. Bradley and Dr. John Amatruda to the Company's Board of Directors
HSMN NewsFeed - 30 Nov 2017
Fractyl Completes $44 Million Series D Financing to Advance New Treatment for Type 2 Diabetes
Fractyl Completes $44 Million Series D Financing to Advance New Treatment for Type 2 Diabetes
HSMN NewsFeed - 24 Oct 2017
Sequana Medical Announces Results of the MOSAIC Trial Data Presented at 2017 AASLD
Sequana Medical Announces Results of the MOSAIC Trial Data Presented at 2017 AASLD
HSMN NewsFeed - 20 Sep 2017
DURECT Appoints Dr. Myriam Theeuwes as Senior Vice President, Clinical Development
DURECT Appoints Dr. Myriam Theeuwes as Senior Vice President, Clinical Development
HSMN NewsFeed - 18 Apr 2017
Allergan Expands Leading Research & Development NASH Program with Novartis Clinical Collaboration
Allergan Expands Leading Research & Development NASH Program with Novartis Clinical Collaboration
HSMN NewsFeed - 11 Feb 2010
NovaShunt Starts its Pivotal Clinical Study "PIONEER" to Demonstrate the Clinical Value of the AFS System
NovaShunt Starts its Pivotal Clinical Study "PIONEER" to Demonstrate the Clinical Value of the AFS System
Additional items found! 2
Members Archive contains
2 additional stories matching:
NAFLD
(Password required)
NAFLD
(Password required)
